The initiative will give Lundbeck closer access to the region’s life science ecosystem, research institutions, talent and potential partners. The company also aims to strengthen its capabilities in digitalisation and AI and support the continued development of its growing neuroscience portfolio.
The relocation is part of the next phase of Lundbeck’s Focused Innovator strategy and the company’s continued investments in the US, which is described as a key market for future growth.
BREAKING